A dialysis client with CKD-mineral and bone disorder is scheduled for denosumab and reports new perioral tingling and muscle spasms. Which action is best?

1 Administer denosumab now and schedule the next calcium test at the routine annual visit.
2 Proceed because regular dialysis prevents clinically important treatment-related hypocalcemia.
3 Hold denosumab and urgently assess calcium and the CKD-mineral bone plan with the authorized team. ✓ Correct answer
4 Ask the client to take an additional denosumab dose independently after dialysis.

Explanation

Advanced CKD and CKD-mineral bone disorder increase the risk of severe denosumab-associated hypocalcemia; symptoms require urgent evaluation before dosing.

Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Treat symptoms as possible severe hypocalcemia in advanced CKD.

Why this is correct
FDA added a boxed warning because denosumab can cause severe, sometimes life-threatening hypocalcemia in advanced CKD, especially with CKD-mineral bone disorder.

Easy analogy or mental picture
Think of medication safety as a control panel: identify the dangerous signal, change the correct control, and verify the response.

Memory hook
Cue, action, response, reassessment.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving the continuing indication.

Why the other choices are wrong
Options that delay escalation, ignore a contraindication, or change therapy without authorization do not close the safety loop.

References

1FDA Drug Safety Communication: Prolia and Advanced CKDBoxed warning for severe hypocalcemia, CKD-mineral bone disorder assessment, supplementation, and monitoring

Clinical scenario

Medication safety review
Verify the indication, current assessment, laboratory trend, timing, interactions, authorized action, and measurable follow-up.

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

A dialysis client with CKD-mineral and bone disorder is scheduled for denosumab and reports new perioral tingling and muscle spasms. Which action is best?

In-depth explanation

Clinical scenario

Master the NCLEX-RN with MyMerci